Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The diagnostic accuracy of the GenoType(®) MTBDRsl assay for the detection of resistance to second-line anti-tuberculosis drugs.

The Cochrane database of systematic reviews - 29 Oct 2014

Theron Grant, Peter Jonny, Richardson Marty, Barnard Marinus, Donegan Sarah, Warren Rob, Steingart Karen R, Dheda Keertan

Abstract excerpt

BACKGROUND: Accurate and rapid tests for tuberculosis (TB) drug resistance are critical for improving patient care and decreasing the transmission of drug-resistant TB. Genotype(®)MTBDRsl (MTBDRsl) is the only commercially-available molecular test for detecting resistance in TB to the fluoroquinolones (FQs; ofloxacin, moxifloxacin and levofloxacin) and the second-line injectable drugs (SLIDs; amikacin, kanamycin...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antitubercular Agents
Share to Cross-Sectional Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Extensively Drug-Resistant Tuberculosis

Share to Fluoroquinolones

Share to Genotype

Share to Microbial Sensitivity Tests

Share to Mycobacterium tuberculosis

Share to Sensitivity and Specificity

Source

Open in PubMed Open full text

Identifiers

PMID: 25353401
DOI: 10.1002/14651858.CD010705.pub2
PMCID: PMC4448219

Genes

DST

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The diagnostic accuracy of the GenoType(®) MTBDRsl assay for the detection of resistance to second-line anti-tuberculosis drugs.PMID 25353401Read ↗

GenoType<sup>®</sup> MTBDR<i>sl</i> assay for resistance to second-line anti-tuberculosis drugsSemantic proximity Read ↗

Detection of resistance to second-line antituberculosis drugs by use of the genotype MTBDRsl assay: a multicenter evaluation and feasibility study.Semantic proximity Read ↗

Rapid diagnosis of drug resistance to fluoroquinolones, amikacin, capreomycin, kanamycin and ethambutol using genotype MTBDRsl assay: a meta-analysis.Semantic proximity Read ↗

Evaluation of the GenoType® MTBDRsl assay for susceptibility testing of second-line anti-tuberculosis drugs.Semantic proximity Read ↗

Evaluation of MTBDRsl for detecting resistance in Mycobacterium tuberculosis to second-line drugs.Semantic proximity Read ↗

Evaluation of Genotype MTBDRsl Assay to Detect Drug Resistance Associated with Fluoroquinolones, Aminoglycosides and Ethambutol on Clinical SedimentsSemantic proximity Read ↗

Performance of GenoType MTBDRsl assay for detection of second-line drugs and ethambutol resistance directly from sputum specimens of MDR-TB patients in Bangladesh.Semantic proximity Read ↗

GenoType MTBDRsl for molecular detection of second-line-drug and ethambutol resistance in Mycobacterium tuberculosis strains and clinical samples.Semantic proximity Read ↗

Second-line Drug Resistance Characterization in Mycobacterium tuberculosis by Genotype MTBDRsl Assay.Semantic proximity Read ↗

GenoType MTBDRsl performance on clinical samples with diverse genetic background.Semantic proximity Read ↗

Direct detection of resistance to fluoroquinolones/SLIDs in sputum specimen by GenoType MTBDRsl v.2.0 assay A study from Eastern Uttar Pradesh, India.Semantic proximity Read ↗

Genotype MTBDRsl version 2 and phenotypic drug resistance detection of Mycobacterium tuberculosis for fluoroquinolones and aminoglycosides.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.